Effect of β-blocker use on outcomes after discharge in patients who underwent cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 1, 2010, Pages

  Chan, Anita Y M ^a,b   McAlister, Finlay A ^a,b   Norris, Colleen M ^a,b   Johnstone, David ^a,b   Bakal, Jeffrey A ^a   Ross, David B ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE CARE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 77953480275     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.03.015     Document Type: Article

References (25)

1. Yusuf S., Peto R., Lewis J., Collins R., and Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27 (1985) 335-371
2. Brophy J.M., Joseph L., and Rouleau J.L. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 134 (2001) 550-560
3. Filion K.B., Pilote L., Rahme E., and Eisenberg M.J. Perioperative use of cardiac medical therapy among patients undergoing coronary artery bypass graft surgery: a systematic review. Am Heart J 154 (2007) 407-414
4. Weightman W.M., Gibbs N.M., Sheminant M.R., Whitford E.G., Mahon B.D., and Newman M.A. Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival. Anesth Analg 88 (1999) 286-291
5. Ferguson Jr. T.B., Coombs L.P., and Peterson E.D. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 287 (2002) 2221-2227
6. ten Broecke P.W., De Hert S.G., Mertens E., and Adriaensen H.F. Effect of preoperative beta-blockade on perioperative mortality in coronary surgery. Br J Anaesth 90 (2003) 27-31
7. Charlson M.E., and Isom O.W. Care after coronary-artery bypass surgery. N Engl J Med 348 (2003) 1456-1463
8. The MACB Study Group. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. Eur Heart J 16 (1995) 1825-1832
9. Goyal A., Alexander J.H., Hafley G.E., Graham S.H., Mehta R.H., Mack M.J., et al. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Ann Thorac Surg 83 (2007) 993-1001
10. Chen J., Radford M.J., Wang Y., Marciniak T.A., and Krumholz H.M. Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?. Arch Intern Med 160 (2000) 947-952
11. Kulik A., Brookhart M.A., Levin R., Ruel M., Solomon D.H., and Choudhry N.K. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation 118 (2008) 1785-1792
12. Eagle K.A., Guyton R.A., Davidoff R., Edwards F.H., Ewy G.A., Gardner T.J., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110 (2004) e340-e437
13. Ghali W.A., and Knudtson M.L. Overview of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease. Can J Cardiol 16 (2000) 1225-1230
14. Mohamed R., McAlister F.A., Pretorius V., Kapoor A.S., Majumdar S.R., Ross D.B., et al. Preoperative statin use and infection after cardiac surgery: a cohort study. Clin Infect Dis 48 (2009) e66-e72
15. D'Agostino R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
16. Graham M.M., Faris P.D., Ghali W.A., Galbraith P.D., Norris C.M., Badry J.T., et al. Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Heart J 142 (2001) 254-261
17. Sipahi I., Tuzcu E.M., Wolski K.E., Nicholls S.J., Schoenhagen P., Hu B., et al. Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials. Ann Intern Med 147 (2007) 10-18
18. Farrokhyar F., Wang X., Kent R., and Lamy A. Early mortality from off-pump and on-pump coronary bypass surgery in Canada: a comparison of the STS and the EuroSCORE risk prediction algorithms. Can J Cardiol 23 (2007) 879-883
19. Okrainec K., Pilote L., Platt R., and Eisenberg M.J. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry. Can J Cardiol 22 (2006) 841-847
20. Kotseva K., Wood D., De Backer G., De Bacquer D., Pyorala K., and Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373 (2009) 929-940
21. Mangano D.T. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
22. Kapoor A.S., Kanji H., Buckingham J., Devereaux P.J., and McAlister F.A. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 333 (2006) 1149-1152
23. Rouleau J.L., Warnica W.J., Baillot R., Block P.J., Chocron S., Johnstone D., et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 117 (2008) 24-31
24. Miceli A., Capoun R., Fino C., Narayan P., Bryan A.J., Angelini G.D., et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 54 (2009) 1778-1784
25. Ferguson Jr. T.B. Secondary prevention after coronary artery bypass graft: a primary issue?. Am Heart J 147 (2004) 948-949